Feed KYTX
Summary
52 / 100 · Bulios Score
Valuation 85Growth 100Profitability -Quality 0Debt 69Stability 1
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
Yes, fastRevenue (USD)
2021202220232024202520262027
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $152.6M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $199.4M
Debt $33.0M
Free cash flow over 12 months -$159.4M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 4
- Hold 0
- Sell 0
Today's price within the analysts' price targets
Today's price $5.69 Average target $25
$5.69 $25
The average target of $25 is 340% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.